Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

Out of the woods

Woodside Energy
3:27pm
January 27, 2024
We upgrade our investment rating on WDS to an Add recommendation, with an upgraded 12-month Target Price of A$34.30ps (was A$33.50). WDS posted a strong finish to the year with a largely in-line 4Q’CY23, although CY24 guidance came in below our estimates/consensus. Importantly subsea work at Scarborough is back underway, with the key offshore project now 55% complete. WDS and STO continue to mutually explore a potential merger. It remains early in the process, but both sides appear motivated.

Time your run

Coronado Global Resources
3:27pm
January 25, 2024
4Q cash flow was again disappointing due to both execution and markets. The reasons driving further sales deferrals – possibly losses – again concern. CRN trades cheaply at (0.87x P/NPV reflecting higher operating risks in recent years and higher balance sheet leverage vs peers. CRN’s appeal for leverage to upside risks in coking coal pricing currently looks challenged by tepid steel markets which pose risks to lower rank met coals around realization and potentially incremental volume in our view.

Pro Medicus Mach 2

Mach7 Technologies
3:27pm
January 25, 2024
M7T has provided a trading update, highlighting an acceleration of trend toward subscription style contracts and away from upfront capital sales. Being paid in installments comes at a near-term cost however, with recognition of these revenues shifting over the life of the contract which is often five years versus the one-and-done upfront sugar hit. A hit this year, but reap the rewards for the next five years. We have long viewed this as a necessary move which will result in a more sustainable and investor friendly business model which more closely resembles that of market darling Pro Medicus. While optically this would appear as a downgrade, the shift supports the valuation over the medium to long term. As a result of our recurring/capital sales weighting changes, our DCF valuation rises marginally to A$1.56ps from A$1.54ps. Add recommendation maintained.

Stretched too thin: Downgrade to Hold

Domino's Pizza
3:27pm
January 24, 2024
We got this one wrong. We thought it possible that Domino’s would snap its streak of missing estimates in 1H24 and deliver a return to growth as sales momentum continued to recover. Domino’s issued a trading update that indicated same store sales have gapped down in Japan, weighing on group earnings and calling into question the strength of the consumer proposition in that market. 1H24 PBT will be $87-90m, below our forecast of $100m and consensus of $103m. We still believe Domino’s will get back to steady same store sales growth and network expansion in time, but it’s taking longer than we expected and the shares are likely to underperform for a while until the company has regained investor confidence. We downgrade from Add to Hold with a $50.00 target price (was $61.00).

System pressures capping near-term upside

IDP Education
3:27pm
January 24, 2024
Canada has announced a two-year cap on new International student visas, expecting to reduce CY24 approvals by ~35% vs CY23. In isolation, earnings impacts from tightening migration and international student policy settings across the major destinations; and visa changes impacting IELTs volumes are manageable. In aggregate, we expect a lower med-term growth profile. The UK election (2HCY24) arguably increases policy risk in the UK. We expect IEL to report a strong 1H24 result, driven by the strength in Student Placement (SP), partially offset with weaker IELTs volume. This composition is arguably weaker, forward looking, given the softening SP growth outlook. IEL continues to offer strong long-term growth. However, we expect uncertainty on announced (and potential) policy change impacts to weigh on the stock. Despite a strong upcoming result, we move to Hold, preferring to have increased confidence in med-term (FY25) earnings at this stage.

A hard earned re-rate

Stanmore Resources
3:27pm
January 24, 2024
4Q production again proved strong but we’re cautious re approaching wet weather. We make several adjustments, trimming our valuation/ target slightly to $4.20ps. Introduction of dividends strongly builds SMR’s appeal to a wider investor base. We maintain an Add, but do note upside has narrowed on SMR’s re-rating. 1H Sales disruption and tepid steel markets could easily uncover better value.

In the doghouse for a while

Nanosonics
3:27pm
January 24, 2024
NAN released a negative trading update, citing hospital budgetary pressures deferring purchasing decisions around new and replacement Trophon units. The timing of the update was surprising to us, and while market trust has clearly diminished following the announcement, we expect management to navigate and adjust as needed. The key will be more detailed guidance at the February result, and while we see the stock as deserving of a de-rate, we continue to see significant value in the install base, superiority over competitors, and Coris potential. Our target price reduces to A$3.88 and we retain our Add recommendation.

Two steps forward one step back

Cooper Energy
3:27pm
January 23, 2024
COE posted a solid 2Q’FY24 production and sales result, while a budget blowout at BMG increases the short-term drag on COE’s balance sheet. 2Q24 group production was 5.68PJe (vs MorgE/consensus 5.4/5.5PJe). New record daily production rate reached at Orbost of 67tj/d. Increased BMG abandonment budget of A$240-$280m (was A$193-$198m). We maintain an Add rating, with an A$0.25ps target price (was A$0.26).

Revises guidance on equipment failure

Karoon Energy
3:27pm
January 23, 2024
KAR has provided an operational update following clearing of the hydrate issue at the SPS88 well, and subsequent mechanical failure. The surface issues are expected to persist until Q4’CY24, with a backlog on regulator approvals currently in Brazil delaying the work required to fix SPS88. KAR has revised CY24 group production guidance to 11.2-13.5mmboe (vs MorgE 12.6mmboe). We maintain an Add rating, with an updated A$2.80ps target price (previously A$2.95).

2Q24 helped by favourable market movements

Generation Development Group
3:27pm
January 23, 2024
GDG’s 2Q24 quarterly update saw a strong Investment bond (IB) sales performance of ~A$156m (+37% on the pcp), albeit with netflows below our expectations (+A$91m versus +A$106m) on higher outflows.  The standout in the quarterly was the very strong IB investment performance (+A$140m), which helped drive FUM up a healthy ~9% over the period. We lift our GDG FY24F/FY25F EPS by 1%-3% on higher IB FUM forecasts in all years. Our target price is set at A$2.01 (previously A$1.91). We continue to believe GDG is well positioned to execute a compound earnings growth story over time. ADD maintained.

News & Insights

Michael Knox, Chief Economist, reveals how the OECD and RBA’s outdated assumptions about global trade fail to account for China’s Marxist-Leninist economic strategies.

This morning, I was asked to discuss Sarah Hunter’s presentation from yesterday. Sarah, the Assistant Governor and Chief Economist at the Reserve Bank of Australia (RBA), delivered a detailed and competent discussion on the conventional view of tariffs’ impact on the international economy. She highlighted that tariffs typically increase inflation and reduce economic output, a perspective echoed by the OECD in a similar presentation overnight. Sarah’s analysis focused on the potential shocks tariffs could cause, particularly their effects on GDP and inflation.

Drawing on my experience as an Australian trade commissioner and my work in Australian embassies, I found her presentation particularly interesting. My background allowed me to bring specialist knowledge to the conversation, which I believe gave me an edge. Notably, I observed that the RBA seems to lack analysts closely tracking individual policymakers in the Trump administration, such as Scott Bessent, whose views on tariffs and competition differ from the general assumptions. The conventional view assumes a world of perfectly competitive countries adhering to international trade rules and unlikely to engage in conflict—a scenario that doesn’t align with the current global trade environment, especially between China and the United States.

China, operating as a Marxist-Leninist economy, aims to dominate global markets by building monopolies in areas like rare earths, nickel, copper, and other base metals. It maintains a managed exchange rate, despite promises to the International Monetary Fund for a freely floating currency. If China allowed its currency, the RMB, to float, it would likely appreciate significantly, increasing imports and reducing its trade surplus. This would create a more balanced international trade environment, potentially reducing the need for other countries to impose tariffs. However, major institutions like the OECD and RBA seem to misjudge the nature of this trade shock, relying on outdated assumptions about global trade dynamics.

The international community also appears to overlook specific U.S. policy intentions, such as those articulated by figures like Peter Navarro and Scott Bessent. The U.S. aims to use tariffs selectively to bolster industries like pharmaceuticals, precision manufacturing, and motor vehicles. This misunderstanding leads public institutions to perceive unspecified risks, as reflected in Sarah’s otherwise able presentation. Because the RBA and similar institutions view the world as fraught with undefined risks, they are inclined to keep interest rates low, responding to perceived threats rather than an equilibrium model.

Interestingly, data from the U.S. economy contradicts the expected negative impacts of tariffs. The Chicago Fed National Activity Indicator, a reliable gauge of economic growth since the 2008 financial crisis, shows U.S. growth above the long-term trend for the first four months of this year. This suggests resilience despite tariff-related shocks. Ideally, growth will slow later this year, prompting the Federal Reserve to cut rates, facilitating a soft landing and a decline in the U.S. dollar to boost global commodity prices. However, this nuanced outlook wasn’t evident in yesterday’s presentation.

Moreover, the anticipated rise in U.S. inflation due to tariffs isn’t materialising. Scott Bessent recently noted that U.S. CPI inflation is lower than expected, with core inflation shown as the (16% trimmed mean) at 3% for the past two months . Core inflation  excluding  food and energy CPI  is only at 2.8%. This suggests that Chinese suppliers are absorbing tariff costs to maintain market share, rather than passing them on as higher prices. Recent Chinese data supports this, showing a slight decline in manufacturing confidence and coal consumption, indicating reduced factory output and electricity use. This points to a modest slowdown in China’s economy. So far the expected negative effects on U.S. prices and output are not occurring.

In summary, the fears expressed by institutions like the RBA and OECD about the Trump administration’s trade policies appear overstated. The U.S. economy is not experiencing the predicted declines in output or increases in inflation. While these effects may emerge later, the current data suggests that the risks are not as severe as anticipated, highlighting a disconnect between theoretical models and real-world outcomes.

Read more
Michael Knox outlines the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and his own analysis for Australia.

Today, I’m presenting the first page of my updated presentation, which focuses on GDP growth and inflation expectations for major economies. Before diving into that, I want to clarify a point about U.S. trade negotiations that has confused some media outlets.

In the previous Trump Administration ,there was single trade negotiator, Robert Lighthizer, held a cabinet position with the rank of Ambassador. This time, to expedite negotiations and give them more weight, Trump has appointed two additional cabinet-level officials to handle trade talks with different regions. For Asian economies, Scott Bessent and Ambassador Jamison Greer, who succeeded Lighthizer and previously served on the White House staff, are managing negotiations, including those with China. For Europe, Howard Lutnick, the Commerce Secretary, and Ambassador Greer are negotiating with the European Trade Representative. When the EU representative visits Washington, D.C., they meet with Lutnick and Greer, while Chinese or Japanese representatives engage with Bessent and Greer.

In my presentation today, I’m outlining the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and my own analysis for Australia.

For the U.S., the best-case scenario is a soft landing, with growth slowing but remaining positive at 1.3% this year and rising to 1.7% next year. This slowdown allows the Federal Reserve to continue cutting interest rates, leading to a decline in the U.S. dollar. This in turn ,triggers a recovery in commodity prices. These prices have stabilized and are now trending upward, with an expected acceleration as the dollar weakens.

U.S. headline inflation is projected to be just below 3% next year, with higher figures this year driven by tariff effects.



Global Economic Perspective

In the Euro area, growth is accelerating slightly, from just under 1% this year to 1.2% next year, with inflation expected to hit the 2% target this year and dip to 1.9% next year.

China’s GDP growth is forecast  at 4% for both this year and next, a step down from previous 5% rates, reflecting a significant slump in domestic demand and very low inflation  Chinese Inflation is only  :   0.2% last year, 0.4% this year, and 0.9% next year.  Despite a massive fiscal push, with a budget deficit around 8% of GDP, China’s debt-to-GDP ratio is rising faster than the U.S.. Yet this is  yielding more modest  domestic growth.

India, on the other hand, continues to outperform, with 6.5% GDP growth last year, 6.2% this year, and  6.3%  next year, surpassing earlier projections.

Read more
In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia.

Positive earnings surprise

In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia. For all the volatility in markets caused by US trade policy, the results were positive. For all the 187 high profile and blue-chip companies in our International Watchlist, the median EPS beat vs consensus was 3.2%, nearly twice that recorded in the December quarter (1.8%). 37% of companies exceeded consensus EPS expectations by more than 5% and only 9% missed by more than 5%. Communication Services was the most positive sector, led by Magnificent 7 companies Alphabet and Meta Platforms. The median EPS beat in that sector was 13%. Consumer Discretionary was the biggest disappointment (though only a mild one) with EPS falling 0.6% short of analyst estimates on a median basis.

Alphabet and Meta among the best performers

Across our Watchlist, some of the best performing stocks in terms of EPS beats were Alphabet, Boeing, Uniqlo-owner Fast Retailing, Meta Platforms, Newmont and The Walt Disney Company. Notable misses came from insurance broker Aon, BP, PepsiCo, Starbucks, Tesla and UnitedHealth. The latter saw by far the worst share price performance over reporting season, its earnings weakness compounded by the resignation of its CEO and the launch of a fraud investigation by the Department of Justice. British luxury fashion label Burberry had the best performing share price as it gains traction in its turnaround plan.

Tariffs were the main talking point (of course)

The timing of President Trump’s ‘Liberation Day’ on 2 April, just before the March quarter results started rolling in, guaranteed that US tariffs would be the main talking point throughout reporting season. Most companies took the line that higher tariffs presented a material risk to global growth and inflation. The rapidly shifting sands of US trade policy mean the impact of tariffs is highly uncertain. This didn’t stop many companies from trying to estimate the impact on their profits. This ranged from the very precise ($850m said RTX) to the extremely vague (‘a few hundred million dollars’ hazarded Abbott Laboratories). The rehabilitation of AI as a systemic driver of long-term value was a key theme of reporting season, with many companies reporting what Palantir Technologies described as an ‘unstoppable whirlwind of demand’ and others indicating an increase in planned AI investment. The deterioration in consumer confidence was another key talking point, though most companies could only express concern about a possible future softening in demand rather than any actual evidence of a hit to sales.

Our International Focus List continues to outperform

In this report, we also report on the performance of the Morgans International Focus List, which is now up 25.3% since inception last year, outperforming the benchmark S&P 500 by 20.4%.


Morgans clients receive exclusive insights such as access to our latest International Reporting Season article.

Contact us today to begin your journey with Morgans.

      
Contact us
      
      
Find an adviser
      
Read more